Over 114,000 vaccine doses administered

A total of 114, 898 doses of the COVID-19 vaccines have been administered in Vanuatu since the rollout of the national vaccination program, until last Sunday.

Vaccination is being administered in the main centers of SHEFA, SANMA, TAFEA, MALAMPA and PENAMA Provinces. Vaccination rollout launch for TORBA Province is scheduled for Tuesday next week.

According to the Ministry of Health (MOH), 48% of the 169, 185 eligible population in all areas have received at least one dose of the COVID-19 vaccine.

For the 146, 623 eligible population in high priority areas, 55% have received at least one dose.

High priority areas are areas identified as being at high risk of COVID-19 importation (international points of entry) or transmission (based on other geographic/demographic considerations), as defined by the National Immunization Coordination Committee in consultation with provincial health teams.

So far, 118,000 doses of COVID-19 vaccines have been received in Vanuatu, comprising 48,000 AstraZeneca doses through COVAX Facility, 20,000 Sinopharm doses from the Chinese Government and 50,000 AstraZeneca from the Australian Government.

Over 72,000 people have received at least one dose of AstraZeneca or Sinopharm and over 32,000 have received two doses of either Sinopharm or AstraZeneca and are considered fully vaccinated.

Of the 369 adverse events recorded following immunization, 15 have been classified as serious and required investigation.

Of these, 15 have required causality assessment with 11 confirmed to be coincidental or immunization anxiety-related and not related to the COVID-19 vaccine product.

For one patient who became ill after being administered with a COVID-19 vaccine, the National Vaccine Safety Expert Advisory Group have concluded following assessment that it is vaccine-product related reaction.

This is the first case of a serious Adverse Event Following Immunization (AEFI) confirmed to be related to the COVID-19 vaccine product administered in Vanuatu.

Tags

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.